Insider Trading & Ownership of COLUMN GROUP L P

Location
San Francisco, CA
Summary
The estimated value of insider holdings of COLUMN GROUP L P is at least $14,433,202 dollars as of 08 Apr 2024. COLUMN GROUP L P is the 10%+ Owner of Nurix Therapeutics, Inc. and owns shares of Nurix Therapeutics, Inc. (NRIX) stock worth about $14.43M. COLUMN GROUP L P is the Director, 10%+ Owner of NGM BIOPHARMACEUTICALS INC and owns shares of NGM BIOPHARMACEUTICALS INC stock worth about $1.3K.
Signature
/s/ James Evangelista, as Attorney-in-fact for The Column Group, LP
All Insider Reports
All Insider Reports

Notify me when COLUMN GROUP L P files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of COLUMN GROUP L P

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NRIX Nurix Therapeutics, Inc. 10%+ Owner $14,431,862 07 May 2021
NGM NGM BIOPHARMACEUTICALS INC Director, 10%+ Owner $1,340 05 Apr 2024

Insider Transactions Reported by COLUMN GROUP L P:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.